Two separate mechanisms for ligand-independent activation of the estrogen receptor

Molecular Endocrinology

Volumn 11, Issue 7, 1997, Pages 928-937

  El Tanani, Mohammed K K ^a   Green, Chris D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0030940838     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.7.9939     Document Type: Article

References (33)

1. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
2. Tsai M-J, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
3. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
4. Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
5. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R 1993 Structure and function of the estrogen receptor. Ann NY Acad Sci 684:119-126
6. Lees JA, Fawell SE, Parker MG 1989 Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 17:5477-5488
7. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P 1989 The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487
8. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike WJ, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
9. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998
10. Couse JF, Curtis SW, Washburn TF, Eddy EM, Schomberg DW, Korach KS 1995 Disruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings. Biochem Soc Trans 23:929-935
11. Chalbos D, Philips A, Galtier F, Rochefort H 1993 Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3′,5′-monophosphate in MCF-7 cells. Endocrinology 133:571-576
12. Smith CL, Conneely OM, O'Malley BW 1993 Modulation of the ligand- independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124
13. Cho H, Aronica SM, Katzenellenbogen BS 1994 Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-1 and serum factors. Endocrinology 134:658-664
14. Ince BA, Montano MM, Katzenellenbogen BS 1994 Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′- monophosphate and ligands including antiestrogens. Mol Endocrinol 8:1397-1406
15. Wakeling AE, Bowler J 1988 Novel antioestrogens without partial agonist activity. J Steroid Biochem 31:645-653
16. Telfer JF, Green CD 1993 Placental alkaline phosphatase activity is inversely related to cell growth rate in HeLaS3 cervical cancer cells. FEBS Lett 329:238-244
17. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P 1989 The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1986
18. Ali S, Metzger D, Bornert J-M, Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12:1153-1160
19. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
20. Bunone G, Briand P-A, Miksicek RJ, Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183
21. Chijiura T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Tashioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesised selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-98), of PC12D pheochromocytoma cells. J Biol Chem 265: 5267-5272
22. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J 1991 The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781
23. Uhler MD, McKnight GS 1987 Expression of cDNAs for two isoforms of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem 262:15202-15207
24. El-Tanani MKK, Green CD 1995 Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells. Mol Cell Endocrinol 111:75-81
25. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS 1994 Phosphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269:4458-4466
26. Joel PB, Traish AM, Lannigan DA 1995 Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052
27. Arnold SF, Varojeikina DP, Notides AC 1995 Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem 270:30205-30212
28. Metzger D, Ali S, Bomert J-M, Chambon P 1995 Characterisation of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542
29. Metzger D, Berry M, Ali S, Chambon P 1995 Effect of antagonists on DNA-binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9:579-591
30. Le Douarin B, vom Baur E, Zechel C, Heery D, Heine M, Vivat V, Gronemeyer H, Losson R, Chambon P 1996 Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Philos Trans R Soc Lond [Biol] 351:569-578
31. Chang T-C, Nardulli AM, Lew D, Shapiro DJ 1992 The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene. Mol Endocrinol 6:346-354
32. Darbre PD, Yates J, Curtis S, King RJB 1983 Effect of estradiol on human breast cancer cells in culture. Cancer Res 43:349-354
33. Chang T-C, Shapiro DJ 1990 An NF1-related vitellogenin activator element mediates transcription from the estrogen-regulated Xenopus laevis vitellogenin promoter. J Biol Chem 265:8176-8182